CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore patent oppositions filed by Chiesi Farmaceutici against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Last updated on: Jul 31, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Drug Delivery Device With ElectronicsNORTON WATERFORDFeb 14, 2020
An Inhalable MedicamentTEVA PHARMACEUTICALSFeb 6, 2020
Solid State Forms Of SelexipagTEVA PHARMACEUTICALSFeb 6, 2020
Inhaler ApparatusCIPLA EUAug 8, 2019
Mesenchymal Stem Cells And Uses ThereforMESOBLASTAug 7, 2019
Inhaler DeviceCIPLAAug 5, 2019

Explore Chiesi Farmaceutici's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Jul 31, 2025
Patent NumberGrant DateTitleTotal Oppositions
Jul 24, 2024Agent For Use In Treatment Or Prevention Of Ophthalmic Disorders1
Jun 26, 2024Micronised Particles Of Low-Dosage Strength Active Agents For Powder Formulations For Inhalation1
Oct 4, 2023Combination Therapy For Copd3
Dec 18, 2019Aerosol Inhalation Device2
Jul 24, 2019Formoterol Superfine Formulation1
Jun 12, 2019Use Of A Composition Comprising Formoterol And Beclometasone Dipropionate For The Prevention And/Or Treatment Of An Exacerbation Of Asthma3
Sep 5, 2018Dry Powder Formulation Comprising An Anticholinergic, A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation1
Jul 11, 2018Dry Powder Formulation Comprising A Corticosteroid And A Beta-Adrenergic For Administration By Inhalation1
May 9, 2018Process For Preparing Carrier Particles For Dry Powders For Inhalation2
Jan 3, 2018"Process For Providing Particles With Reduced Electrostatic Charges"1

Top competitors of Chiesi Farmaceutici

List of top competitors of Chiesi Farmaceutici based on patent oppositions.